Effect of Teduglutide, a Glucagon-like Peptide 2 Analog, on Citrulline Levels in Patients With Short Bowel Syndrome in Two Phase III Randomized Trials

類似資料

• Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome
  著者:: Jeppesen, Palle Bekker
  出版事項: (2012)
• Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome
  著者:: Schwartz, Lauren K, 等
  出版事項: (2016)
• Teduglutide for short bowel syndrome
  出版事項: (2020)
• Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials
  著者:: Seidner, Douglas L., 等
  出版事項: (2019)
• Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide
  著者:: Fujioka, Ken, 等
  出版事項: (2016)